NASDAQ · Biotechnology

Chemomab Therapeutics Ltd. (CMMB) Stock

$1.43 -2.72% NASDAQ: CMMB Healthcare

Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions.

Valuation

MetricValue
Price$1.43
Market Cap$8.80M
P/E Ratio-1.30
P/B Ratio1.07
P/S Ratio0.00
EPS (TTM)$-1.42
52-Week High$4.80
52-Week Low$1.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-67.85%
ROA-63.15%
ROCE-74.26%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio10.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-12.0M$-29.0M$-25.0M$-15.0M$-10.0M
Net Profit$-12.0M$-28.0M$-24.0M$-14.0M$-9.0M
EPS$-4.80$-9.68$-8.22$-3.12$-1.42
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$64.0M$43.0M$22.0M$17.0M$14.0M
Total Liabilities$3.0M$7.0M$5.0M$3.0M$1.0M
Cash$15.0M$14.0M$9.0M$6.0M$8.0M
Borrowings$0$0$0$0$0

Latest News

Top Midday Decliners MT Newswires · Jul 8, 2026 Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis GlobeNewswire · Jul 8, 2026 Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-12.0M$-20.0M$-24.0M$-15.0M$-11.0M
Investing Cash Flow$-45.0M$19.0M$16.0M$2.0M$5.0M
Financing Cash Flow$2.0M$-1.0M$0$0$0
Net Cash Flow$56.0M$-48.0M$-4.0M$-3.0M$1.0M
Free Cash Flow$-13.0M$-20.0M$-24.0M$-15.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.37
FCF Yield-127.49%
Quick Ratio10.31
Interest Coverage0.00
Return 1Y-68.08%
Return 3Y-73.52%
Return 5Y-97.98%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental drug candidate, CM-101, is a humanized monoclonal antibody specifically engineered to impede the core function of soluble chemokine CCL24. This potential therapy is currently under investigation for its efficacy in managing primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Established in 2011, the company, formerly known as Anchiano Therapeutics Ltd., adopted its current name, Chemomab Therapeutics Ltd., in March 2021 and is headquartered in Tel Aviv, Israel.

Chemomab Therapeutics Ltd. is headquartered in IL.

Chemomab Therapeutics Ltd. (CMMB) stock trades at $1.43 with a market capitalization of $8.80M. The stock is valued at a price-to-earnings (P/E) ratio of -1.30, price-to-book of 1.07, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.35 and $4.80, and currently trades 70.2% below its 52-week high.

On profitability, Chemomab Therapeutics Ltd. generates a return on equity (ROE) of -67.85%, return on capital employed of -74.26%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.chemomab.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides